Kymriah becomes first CAR T available on NHS England

Novartis AG (NYSE:NVS; SIX:NOVN) said it has reached an agreement with NHS England to make Kymriah tisagenlecleucel available in England, which the agency said marks

Read the full 256 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE